County of Monroe v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-45158 |
| Nature of Suit | 470 Other Statutes - Racketeer Influenced and Corrupt Organizations |
| Cause | 18:1962 Racketeering (RICO) Act |
| Case Filed: | Feb 07, 2018 |
| Case in other court: | Michigan Eastern, 2:18-cv-10251 |
| Last checked: Friday Nov 08, 2019 5:12 PM EST |
|
*** SELECTION REQUIRED
Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Rite Aid of Maryland, Inc.
|
Represented By
|
|
Defendant
Mallinckrodt Pharmaceuticals
|
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Noramco, Inc.
|
Represented By
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Purdue Frederick Company, Inc., The
|
|
|
Defendant
Purdue Pharma L.P.
|
|
|
Defendant
Purdue Pharma, Inc.
|
|
|
Defendant
Mallinckrodt LLC
|
Represented By
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Wal-Mart Inc.
|
Represented By
|
|
Defendant
Walgreen Co.
|
Represented By
|
|
Defendant
Walgreen Eastern Co., Inc.
|
Represented By
|
|
Defendant
Watson Laboratories, Inc.
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC f/k/a Actavis Inc, f/k/a Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
CVS Indiana, LLC
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions, Inc.
|
|
|
Defendant
Endo International plc
|
|
|
Defendant
Endo Pharmaceuticals Inc.
|
|
|
Defendant
Insys Therapeutics, Inc.
|
|
|
Defendant
Janssen Pharmaceutica, Inc.
|
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Kroger Co.
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Plaintiff
County of Monroe
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Rite Aid Corporation
Terminated: 07/06/2018
|
Represented By
|
|
Defendant
Walgreens Boots Alliance, Inc.
Terminated: 07/16/2018
|
Represented By
|
|
Defendant
CVS Health Corporation
Terminated: 07/16/2018
|
Represented By
|
| Docket last updated: 04/08/2019 7:28 PM EDT |
| Monday, January 22, 2018 | ||
| 1 | 1
190
pgs
COMPLAINT filed by All Plaintiffs against All Defendants with Jury Demand. Plaintiff requests summons issued. Receipt No: 0645-6565105 - Fee: $ 400. County of 1st Plaintiff: Monroe - County Where Action Arose: Monroe - County of 1st Defendant: Fairfield. [ Previously dismissed case: No] [ Possible companion case(s): None ] (Miller, E.) [Transferred from mied on 2/7/2018.]
|
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 1 Michigan Governor Press Release,
|
||
|
Att: 3
Exhibit 2 Michigan Prescription Drug Commission,
|
||
|
Att: 4
Exhibit 3 Increases in Drug and Opioid-Involved Overdose Deaths,
|
||
|
Att: 5
Exhibit 4 Overdose Death Rates,
|
||
|
Att: 6
Exhibit 5 Casualties of the Vietnam War,
|
||
|
Att: 7
Exhibit 6 Midwest Intervention Group,
|
||
|
Att: 8
Exhibit 7 Drug and Alcohol Dependence- Heroin Use,
|
||
|
Att: 9
Exhibit 8 Purdue Pharma-Corporate Fraud with a Body Count,
|
||
|
Att: 10
Exhibit 9 Inside a Killer Drug Epidemic-Americas Opioid Crisis,
|
||
|
Att: 11
Exhibit 10 The Family That Built an Empire of Pain,
|
||
|
Att: 12
Exhibit 11 How the Opioid Epidemic Became Americas Worst Drug Crisis Ever,
|
||
|
Att: 13
Exhibit 12 Monroe County to Sue Drug Companies Regarding the Opioid Crisis,
|
||
|
Att: 14
Exhibit 13 2nd Annual Opioid Abuse and Heroin Overdose Solutions Summit,
|
||
|
Att: 15
Exhibit 14 Fatal Fentanyl in Monroe County,
|
||
|
Att: 16
Exhibit 15 OxyContin Goes Global,
|
||
|
Att: 17
Exhibit 16 Systemic Review: Opioid Treatment for Chronic Back Pain,
|
||
|
Att: 18
Exhibit 17 The Risk of a Single 5-Day Opioid Prescription,
|
||
|
Att: 19
Exhibit 18 Opioid Painkiller Prescribing Infographic,
|
||
|
Att: 20
Exhibit 19 Pill Mill Doctor Gets 4 Years Prison for Giving Painkillers,
|
||
|
Att: 21
Exhibit 20 Pill Mill Doctor Pleads Guilty,
|
||
|
Att: 22
Exhibit 21 Monroe Doctors Medical License Suspended,
|
||
|
Att: 23
Exhibit 22 Drug Distributors Penalized for Turning Blind Eye,
|
||
|
Att: 24
Exhibit 23 This One-Paragraph Letter May Have Launched the Opioid Epidemic,
|
||
|
Att: 25
Exhibit 24 A 5-Sentence Letter Helped Trigger Americas Deadliest Drug Crisis,
|
||
|
Att: 26
Exhibit 25 The Presidents Commission on Combating Drug Addiction and the Opioid Crisis,
|
||
|
Att: 27
Exhibit 26 Who is Responsible for the Pain-Pill Epidemic?,
|
||
|
Att: 28
Exhibit 27 Opioids for Chronic Pain: Addiction is NOT Rare,
|
||
|
Att: 29
Exhibit 28 AAPM Facts and Figures on Pain,
|
||
|
Att: 30
Exhibit 29 A Pain-Drug Champion Has Second Thoughts,
|
||
|
Att: 31
Exhibit 30 FSMB Letter,
|
||
|
Att: 32
Exhibit 31 Pain: Current Understanding of Assessment, Management, and Treatments,
|
||
|
Att: 33
Exhibit 32 Report to Congressional Requesters: Prescription Drugs,
|
||
|
Att: 34
Exhibit 33 American Pain Foundation Shuts Down,
|
||
|
Att: 35
Exhibit 34 A Guide for People Living with Pain,
|
||
|
Att: 36
Exhibit 35 Lets Talk Pain: Safe Use of Opioids,
|
||
|
Att: 37
Exhibit 36 The Effectiveness and Risks of Long-Term Opioid Treatment,
|
||
|
Att: 38
Exhibit 37 Reducing the Risks of Relief-The CDC Guideline,
|
||
|
Att: 39
Exhibit 38 Opioid Abuse in Chronic Pain,
|
||
|
Att: 40
Exhibit 39 Pain: Opioid Facts,
|
||
|
Att: 41
Exhibit 40 A Policymakers Guide to Understanding Pain & its Management,
|
||
|
Att: 42
Exhibit 41 Opioids for Chronic Noncancer Pain,
|
||
|
Att: 43
Exhibit 42 Patient Advocacy Group Funded by Success of Painkiller Drugs,
|
||
|
Att: 44
Exhibit 43 Opioid Treatment Guidelines,
|
||
|
Att: 45
Exhibit 44 About The Alliance for Patient Access,
|
||
|
Att: 46
Exhibit 45 Non-Profit Alliance for Patient Access uses Journalists and Politicians to Push Big Pharmas Agenda,
|
||
|
Att: 47
Exhibit 46 FBI Seizes Records of Overland Park Pain Doctor Tied to Insys,
|
||
|
Att: 48
Exhibit 47 Preserving Patient Access While Curbing Abuse,
|
||
|
Att: 49
Exhibit 48 Patient and Health Professional Groups Letter of Support,
|
||
|
Att: 50
Exhibit 49 Ex-DEA Agent: Opioid Crisis Fueled By Drug Industry and Congress,
|
||
|
Att: 51
Exhibit 50 Current Navigation Points in Drug Diversion Law
|
||
| 2 | 2
EXHIBIT re1 Complaint,,,,,,,,,,,,,,, by County of Monroe (Miller, E.) [Transferred from mied on 2/7/2018.]
|
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 51 Opioid Makers Plied Doctors with Perks,
|
||
|
Att: 3
Exhibit 52 The Speakers Bureau System: A Form of Peer Selling,
|
||
|
Att: 4
Exhibit 53 Speakers Bureaus: Best Practices for Academic Medical Centers,
|
||
|
Att: 5
Exhibit 54 Two Leaders in Pain Treatment Have Long Ties to Drug Industry,
|
||
|
Att: 6
Exhibit 55 Doctor: 1,500 Pills Dont Prove Smith Was Addicted,
|
||
|
Att: 7
Exhibit 56 Follow the Money: Pain, Policy and Profit,
|
||
|
Att: 8
Exhibit 57 SFC Opioid Investigation Letter to APS,
|
||
|
Att: 9
Exhibit 58 Senators Must Do Their Jobs and Release Sealed Opioids Report,
|
||
|
Att: 10
Exhibit 59 Senator McCaskill Opens Investigation Into Opioid Manufacturersd,
|
||
|
Att: 11
Exhibit 60 How Big Pharma Got People Hooked on Dangerous Opioids,
|
||
|
Att: 12
Exhibit 61 The Promotion and Marketing of OxyContin,
|
||
|
Att: 13
Exhibit 62 Opioid Painkiller Prescribing,
|
||
|
Att: 14
Exhibit 63 OxyContin: Purdue Pharmas Painful Medicine,
|
||
|
Att: 15
Exhibit 64 See Trend of Opioid/Heroin Deaths in Your Michigan County,
|
||
|
Att: 16
Exhibit 65 What is the Difference Between Agonist and Antagonist Drugs?,
|
||
|
Att: 17
Exhibit 66 Dilaudid Addiction,
|
||
|
Att: 18
Exhibit 67 OxyContins 12-Hour Problem,
|
||
|
Att: 19
Exhibit 68 Long-Acting OxyContin Tablets Now Available to Relieve Pain,
|
||
|
Att: 20
Exhibit 69 In Guilty Plea, OxyContin Maker to Pay $600 Million,
|
||
|
Att: 21
Exhibit 70 More Than 1 Million OxyContin Pills Ended Up in the Hands of Criminals and Addicts,
|
||
|
Att: 22
Exhibit 71 Purdue Pharma Agrees to Restrict Marketing of Opioids,
|
||
|
Att: 23
Exhibit 72 Safe and Effective Opioid Rotation,
|
||
|
Att: 24
Exhibit 73 American Pain Foundation Organization Report,
|
||
|
Att: 25
Exhibit 74 Statement of United States Attorney John Brownlee,
|
||
|
Att: 26
Exhibit 75 Letter to Assistant Director of Regulatory Affairs at Janssen Pharmacuetica,
|
||
|
Att: 27
Exhibit 76 Warning Letter to CEO of Janssen Pharmaceutica, Inc.,
|
||
|
Att: 28
Exhibit 77 Pain Management for Older Adults,
|
||
|
Att: 29
Exhibit 78 Janssen Pharmaceuticals, Inc. Legal Notice,
|
||
|
Att: 30
Exhibit 79 Use of Opioid Analgesics in Pain Management,
|
||
|
Att: 31
Exhibit 80 What a Prescriber Should Know Before Writing the First Prescription,
|
||
|
Att: 32
Exhibit 81 Opana Gets FDA Approval Despite History,
|
||
|
Att: 33
Exhibit 82 How a Painkiller Designed to Deter Abuse Helped Spark an HIV Outbreak,
|
||
|
Att: 34
Exhibit 83 CDC Health Advisory: Outbreak of HIV and HCV Infections,
|
||
|
Att: 35
Exhibit 84 A.G. Schneiderman Announces Settlement with Endo Health Solutions Inc. & Endo Pharmaceuticals Inc.,
|
||
|
Att: 36
Exhibit 85 Assurance of Discontinuance Under Executive Law,
|
||
|
Att: 37
Exhibit 86 Opioid Therapy for Chronic Pain,
|
||
|
Att: 38
Exhibit 87 Taking Oral Opioid Analgesics,
|
||
|
Att: 39
Exhibit 88 Resources for Education on Pain and Its Management,
|
||
|
Att: 40
Exhibit 89 About PainKnowledge.org,
|
||
|
Att: 41
Exhibit 90 Iraq War Veteran Amputee, Pain Advocate and New Author,
|
||
|
Att: 42
Exhibit 91 FDA Requests Removal of Opana ER for Risks Related to Abuse,
|
||
|
Att: 43
Exhibit 92 Narcotic Lollipop Becomes Big Seller Despite FDA Curbs,
|
||
|
Att: 44
Exhibit 93 Cephalon, Inc.- Company History,
|
||
|
Att: 45
Exhibit 94 Letter to Anesta Corporation,
|
||
|
Att: 46
Exhibit 95 Cephalon Form 10-K U.S. Securities and Exchange Commission,
|
||
|
Att: 47
Exhibit 96 DOJ PR-Cephalon to Pay $425 Million for Off-Label Drug Marketing,
|
||
|
Att: 48
Exhibit 97 Cephalon Used Improper Tactics to Sell Drug,
|
||
|
Att: 49
Exhibit 98 Cephalon Q1 2007 Earnings Call Transcript,
|
||
|
Att: 50
Exhibit 99 FDA Public Health Advisory: Information for the Safe Use of Fentora,
|
||
|
Att: 51
Exhibit 100 FDA Joint Meeting of Anesthetic and Life Support Drugs
|
||
| 3 | 3
EXHIBIT re2 Exhibit,,,,,,,,,,,,,,1 Complaint,,,,,,,,,,,,,,, by County of Monroe (Miller, E.) [Transferred from mied on 2/7/2018.]
|
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 101 An Integrated Risk Evaluation and Mitigation Strategy for Fentora,
|
||
|
Att: 3
Exhibit 102 Pharmacologic Management of Breakthrough or Incident Pain,
|
||
|
Att: 4
Exhibit 103 Treatment Rational with Opioids,
|
||
|
Att: 5
Exhibit 104 Oral Transmucosal Fentanyl Citrate for the treatment of Migraine Headache Pain in Outpatients,
|
||
|
Att: 6
Exhibit 105 Optimizing Opioid Treatment for Breakthrough Pain,
|
||
|
Att: 7
Exhibit 106 Opioid-Based Management of Persistent and Breakthrough Pain,
|
||
|
Att: 8
Exhibit 107 A Drug Company Putting Profits Above Patients,
|
||
|
Att: 9
Exhibit 108 Notice of Unlawful Trade Practices and Proposed Resolution-Insys,
|
||
|
Att: 10
Exhibit 109 Doubt Raised About Off-Label Use of Subsys,
|
||
|
Att: 11
Exhibit 110 Pharmaceutical Executives Charged in Racketeering Scheme,
|
||
|
Att: 12
Exhibit 111 Insys Therapeutics Grand Jury Indictment,
|
||
|
Att: 13
Exhibit 112 Opioid Billionaire Arrested On Racketeering Charges,
|
||
|
Att: 14
Exhibit 113 Mallinckrodt Announces Agreement with Xanodyne to Purchase Roxicodone,
|
||
|
Att: 15
Exhibit 114 Pain Treatment Topics- Access to Clinical news, Information, Research and Education,
|
||
|
Att: 16
Exhibit 115 Oxycodone Safety Handout for Patients,
|
||
|
Att: 17
Exhibit 116 Pain Treatment Topics-FAQs,
|
||
|
Att: 18
Exhibit 117 Commonsense Oxycodone Prescribing & Safety,
|
||
|
Att: 19
Exhibit 118 Donald Trumps Pick to Oversee big Pharma is Addicted to Opioid- Industry Cash,
|
||
|
Att: 20
Exhibit 119 The Governments Struggle to Hold Opioid Manufacturers Accountable,
|
||
|
Att: 21
Exhibit 120 HDAs Annual Circle Sponsors,
|
||
|
Att: 22
Exhibit 121 Ex-DEA Official Says Congress is Protecting Drug Makers,
|
||
|
Att: 23
Exhibit 122 Red Flags: Pharmacists Anti-Abuse Video,
|
||
|
Att: 24
Exhibit 123 Mallinckrodt to Pay $35M in Deal to End Feds Opioid Probe,
|
||
|
Att: 25
Exhibit 124 Mallinckrodt Agrees to Pay Record $35 Million Settlement,
|
||
|
Att: 26
Exhibit 125 Whistleblowers: DEA Attorneys Went Easy on McKesson,
|
||
|
Att: 27
Exhibit 126 Cardinal Health Agrees to $44 Million Settlement,
|
||
|
Att: 28
Exhibit 127 Wikipedia- AmerisourceBergen,
|
||
|
Att: 29
Exhibit 128 Drug Distribution Locations-Mainland US,
|
||
|
Att: 30
Exhibit 129 Drug Firms Poured $780M Painkillers Into WV Amid Overdoses
|
||
| 4 | 4
NOTICE of Appearance by Sharon S. Almonrode on behalf of County of Monroe. (Almonrode, Sharon) [Transferred from mied on 2/7/2018.]
|
|
| Tuesday, January 23, 2018 | ||
| A United States Magistrate Judge of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form is available for download at[LINK:http://www.mied.uscourts.gov] (DAll) [Transferred from mied on 2/7/2018.] | ||
| 5 | 5
SUMMONS Issued for *Amerisourcebergen Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo International PLC, Endo Pharmaceuticals Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Mallinckrodt PLC, Mallinckrodt Pharmaceuticals, McKesson Corporation, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.* (DAll) [Transferred from mied on 2/7/2018.]
|
|
| Tuesday, February 06, 2018 | ||
| 6 | 6
MDL Certified Conditional Transfer Order (CTO-7) for MDL # 2804. [Informational Copy] (SSch) [Transferred from mied on 2/7/2018.]
|
|
| Wednesday, February 07, 2018 | ||
| 7 | 7
MDL Certified Conditional Transfer Order (CTO-7) to Northern District of Ohio for MDL # 2804. (SSch) [Transferred from mied on 2/7/2018.]
|
|
| 8 | 8
NOTICE of Transfer to the Northern District of Ohio for MDL 2804 (SSch) [Transferred from mied on 2/7/2018.]
|
|
| 9 | 9
CASE TRANSFERRED IN from District of Michigan Eastern. Case number 2:18-cv-10251. Original file, certified copy of transfer order and docket sheet received.
|
|